SU5214
Product Specifications
UNSPSC Description
SU5214 is a potent VEGFR2 inhibitor extracted from patent US5834504A, SU5214, has IC50s of 14.8 µM (FLK-1) and 36.7 µM (EGFR), respectively[1].
Target Antigen
VEGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/su5214.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1NC2=C(C=CC=C2)/C1=C/C3=CC=CC=C3OC
Molecular Weight
251.28
References & Citations
[1]Tang et al. 3-(2'-halobenzylidenyl)-2-indolinone compounds for the treatment of disease. US5834504A.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-21292/SU5214-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-21292/SU5214-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
186611-04-1
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Cuscuta exaltata Cytochrome b6-f complex subunit 5 (petG), partial
Recombinant Cuscuta exaltata Cytochrome b6-f complex subunit 5 (petG), partial
Regulated On Activation In Normal T-Cell Expressed And Secreted (RANTES) Antibody (FITC)
